vaccine
Kenya is prioritizing domestic vaccine production to enhance its preparedness for future health crises and reduce reliance on imported vaccines. The nation’s experience during the COVID-19 pandemic, where Africa faced delays in vaccine access, has spurred this initiative. Vaccine Manufacturing Initiative Kenya aims to produce 60–70% of its vaccine supply locally, establishing the Kenya Biobank […]
Nairobi, Kenya – January 12, 2026 Health Cabinet Secretary Aden Duale met with the Board and Senior Management of the Kenya BioVax Institute. The meeting reaffirmed the government’s dedication to local vaccine manufacturing as a key element of Kenya’s Universal Health Coverage (UHC) plan. Institute Mandate and Progress The Kenya BioVax Institute’s mandate is to […]
-
Pages